1. Home
  2. WALD vs CNXU Comparison

WALD vs CNXU Comparison

Compare WALD & CNXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Waldencast plc

WALD

Waldencast plc

HOLD

Current Price

$1.33

Market Cap

187.3M

ML Signal

HOLD

Logo Conexeu Sciences Inc. Common Stock

CNXU

Conexeu Sciences Inc. Common Stock

N/A

Current Price

$4.46

Market Cap

215.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WALD
CNXU
Founded
1988
N/A
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
187.3M
215.9M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
WALD
CNXU
Price
$1.33
$4.46
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
159.2K
262.5K
Earning Date
03-13-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.89
N/A
Revenue Next Year
$4.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.72
$4.65
52 Week High
$3.22
$13.66

Technical Indicators

Market Signals
Indicator
WALD
CNXU
Relative Strength Index (RSI) 45.05 27.62
Support Level $1.24 N/A
Resistance Level $1.83 $10.41
Average True Range (ATR) 0.07 0.78
MACD 0.01 -0.29
Stochastic Oscillator 45.24 1.20

Price Performance

Historical Comparison
WALD
CNXU

About WALD Waldencast plc

Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.

About CNXU Conexeu Sciences Inc. Common Stock

Conexeu Sciences Inc is an early-stage medical technology company. The company develops and supplies collagen-based technologies that helps doctors and patients regenerate tissue naturally, safely, and effectively. The company is focused on developing regenerative biomaterials that address relative needs in wound care, dentistry, and aesthetics. The company seek to provide physicians with device-based solutions that improve healing, restore soft tissue, and enhance patient outcomes across multiple clinical settings. The company focuses durable, and growing addressable markets in regenerative aesthetics, wound care, 3D-printed tissue structures, veterinary wound repair, and dental soft-tissue regeneration.

Share on Social Networks: